Literature DB >> 17953465

New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines.

Kym J Guelfi1, Timothy W Jones, Paul A Fournier.   

Abstract

Exercise is generally recommended for individuals with type 1 diabetes mellitus since it is associated with numerous physiological and psychological benefits. However, participation in exercise can also increase the risk of experiencing severe hypoglycaemia, a potentially life-threatening condition, both during exercise and for up to 31 hours of recovery. Fortunately, this risk of exercise-induced hypoglycaemia can be managed by adjusting the dosage of self-administered exogenous insulin and nutritional intake to maintain blood glucose levels within the normal physiological range. In order to provide evidence-based guidelines to allow individuals with type 1 diabetes to safely participate in a range of physical activities, much previous research has focused on understanding the metabolic and hormonal responses to exercise. Consequently, it is well established that moderate- and high-intensity exercise have a contrasting effect on blood glucose levels and require different management strategies to maintain euglycaemia. On the other hand, the response of blood glucose levels to a combination of moderate- and high-intensity exercise, a pattern of physical activity referred to as intermittent high-intensity exercise (IHE) has received little research attention. This is despite the fact that this type of exercise characterises the activity patterns of most team and field sports as well as spontaneous play in children. The lack of previous research into the glucoregulatory responses to IHE is reflected in existing guidelines, which either do not address IHE, or suggest similar management strategies for blood glucose levels during and after IHE as for moderate- or high-intensity exercise alone. It is important, however, to appreciate that there are fundamental differences in the metabolic responses to intermittent exercise compared with other types of exercise. Recently, a series of investigations into the glucoregulatory responses to IHE that replicates the work-to-recovery ratios observed in team and field sports have been conducted. The findings of these studies do not support the existing recommendations for managing blood glucose levels during IHE. Hence, the purpose of this article is to discuss the results of these recent studies, which provide new insight into the management of blood glucose levels during and after IHE and have implications for current guidelines aimed at minimising the risk of hypoglycaemia. These findings, along with future investigations, should provide valuable information for health professionals and individuals with type 1 diabetes on the management of blood glucose levels during and after exercise to allow for safe participation in intermittent activities along with their peers.

Entities:  

Mesh:

Year:  2007        PMID: 17953465     DOI: 10.2165/00007256-200737110-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  52 in total

1.  Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia.

Authors:  G E Sonnenberg; F W Kemmer; M Berger
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

2.  Intermittent high-intensity exercise does not increase the risk of early postexercise hypoglycemia in individuals with type 1 diabetes.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

3.  The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

4.  Glycemic control during exercise in type 1 diabetes: comparison of a new medical food bar with usual care.

Authors:  S J Bell; J Kistler; C A Mullooly; K B Ovalle; B Zilvitis; R A Forse
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

5.  Effect of gender on counterregulatory responses to euglycemic exercise in type 1 diabetes.

Authors:  Pietro Galassetti; Donna Tate; Ray A Neill; Sachiko Morrey; Stephen N Davis
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

Review 6.  Overview of diabetes mellitus and exercise.

Authors:  J M Ekoé
Journal:  Med Sci Sports Exerc       Date:  1989-08       Impact factor: 5.411

7.  Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes.

Authors:  P R Galassetti; K Iwanaga; A M Pontello; F P Zaldivar; R L Flores; J K Larson
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-06       Impact factor: 4.310

Review 8.  Diabetes and exercise.

Authors:  N S Peirce
Journal:  Br J Sports Med       Date:  1999-06       Impact factor: 13.800

9.  Responses to continuous and intermittent exercise in healthy and insulin-dependent diabetic children.

Authors:  I N Sills; F J Cerny
Journal:  Med Sci Sports Exerc       Date:  1983       Impact factor: 5.411

10.  Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.

Authors:  S Shilo; M Sotsky; H Shamoon
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

View more
  8 in total

1.  Antecedent hypoglycaemia does not diminish the glycaemia-increasing effect and glucoregulatory responses of a 10 s sprint in people with type 1 diabetes.

Authors:  Raymond J Davey; Nirubasini Paramalingam; Adam J Retterath; Ee Mun Lim; Elizabeth A Davis; Timothy W Jones; Paul A Fournier
Journal:  Diabetologia       Date:  2014-03-16       Impact factor: 10.122

Review 2.  Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring.

Authors:  Michael Riddell; Bruce A Perkins
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 3.  Quantifying the acute changes in glucose with exercise in type 1 diabetes: a systematic review and meta-analysis.

Authors:  Fernando García-García; Kavita Kumareswaran; Roman Hovorka; M Elena Hernando
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

4.  The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes.

Authors:  Matthew Stenerson; Fraser Cameron; Darrell M Wilson; Breanne Harris; Shelby Payne; B Wayne Bequette; Bruce A Buckingham
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

5.  Effect of antecedent moderate-intensity exercise on the glycemia-increasing effect of a 30-sec maximal sprint: a sex comparison.

Authors:  Tara D Justice; Greta L Hammer; Raymond J Davey; Nirubasini Paramalingam; Kym J Guelfi; Lynley Lewis; Elizabeth A Davis; Timothy W Jones; Paul A Fournier
Journal:  Physiol Rep       Date:  2015-05

6.  A 10-s sprint performed after moderate-intensity exercise neither increases nor decreases the glucose requirement to prevent late-onset hypoglycemia in individuals with type 1 diabetes.

Authors:  Raymond J Davey; Vanessa A Bussau; Nirubasini Paramalingam; Luis D Ferreira; Ee Mun Lim; Elizabeth A Davis; Timothy W Jones; Paul A Fournier
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

7.  Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus.

Authors:  Othmar Moser; Julia K Mader; Gerhard Tschakert; Alexander Mueller; Werner Groeschl; Thomas R Pieber; Gerd Koehler; Janin Messerschmidt; Peter Hofmann
Journal:  Nutrients       Date:  2016-08-10       Impact factor: 5.717

8.  Routine daily physical activity and glucose variations are strongly coupled in adults with T1DM.

Authors:  Sarah S Farabi; David W Carley; Ali Cinar; Lauretta Quinn
Journal:  Physiol Rep       Date:  2015-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.